Evaluation of the Trajectory of Depression Severity With Ketamine and Esketamine Treatment in a Clinical Setting
JAMA Psychiatry May 11, 2022 Sina Nikayin, Taeho Greg Rhee, Maria Elena Cunningham et al. 43 citations
In a clinical setting, patients treated with intravenous ketamine or intranasal esketamine showed similar trajectories of depression severity over time, suggesting both treatments are comparably effective for depression.